Search - tctmd.com

Displaying 41 - 49 of 49

Sort: Relevancy | Date

Presentation TCT 2016

Case #2 - Resolution: Did We Close It (?), and Long-term Patient Outcomes

Presenter: John D. Carroll, David E. Thaler, Ted Feldman

November 01, 2016

Presentation TCT 2016

Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved?

Presenter: John D. Carroll, David E. Thaler, Ted Feldman

November 01, 2016

Presentation TCT 2016

Case #1 Resolution: Did We Close It (?), and Long-term Patient Outcomes

Presenter: John D. Carroll, David E. Thaler, Mark Reisman

November 01, 2016

Presentation TCT 2016

Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke

Presenter: John D. Carroll, David E. Thaler, Mark Reisman

November 01, 2016

News Conference News TCT 2016

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

Presenter: Howard C. Herrmann, Robert J. de Winter, David E. Thaler

November 01, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Opinion Editor's Corner TCT 2016

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Shelley Wood

October 24, 2016

Presentation

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Presenter: David M. Kent

February 22, 2016

Advertisement

Case #2 - Resolution: Did We Close It (?), and Long-term Patient Outcomes

Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved?

Case #1 Resolution: Did We Close It (?), and Long-term Patient Outcomes

Case #1 - Introduction: Severe Migraines With Evidence of Cortical Stroke

Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention

RESPECT: Final Long-term Outcomes From a Prospective, Randomized Trial of PFO Closure in Patients With Cryptogenic Stroke

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

TCT 2016: Inspiration and Perspiration Greet Left Main Stenting, Hoop Dreams, Valve Innovation, and Election Fever

Device Closure of PFO After Stroke: Pooled Analysis of Completed Randomized Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content